Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4580738
Max Phase: Preclinical
Molecular Formula: C55H89N2O14PS
Molecular Weight: 1065.36
Molecule Type: Unknown
Associated Items:
ID: ALA4580738
Max Phase: Preclinical
Molecular Formula: C55H89N2O14PS
Molecular Weight: 1065.36
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(\C)C(N3CCCS3(=O)=O)C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)CC[C@H]1OP(C)(C)=O
Standard InChI: InChI=1S/C55H89N2O14PS/c1-35-18-13-12-14-19-37(3)45(57-28-17-29-73(57,65)66)34-43-24-22-41(7)55(63,70-43)52(60)53(61)56-27-16-15-20-44(56)54(62)69-46(38(4)32-42-23-26-47(48(33-42)67-8)71-72(10,11)64)25-21-36(2)31-40(6)50(59)51(68-9)49(58)39(5)30-35/h12-14,18-19,31,35-36,38-39,41-48,50-51,59,63H,15-17,20-30,32-34H2,1-11H3/b14-12+,18-13+,37-19+,40-31+/t35-,36+,38-,39-,41-,42+,43+,44+,45?,46+,47-,48-,50-,51+,55-/m1/s1
Standard InChI Key: OGXIPDVLRGUPQZ-XZCRSXPXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1065.36 | Molecular Weight (Monoisotopic): 1064.5772 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Abdel-Magid AF.. (2019) Rapalogs Potential as Practical Alternatives to Rapamycin., 10 (6): [PMID:31223435] [10.1021/acsmedchemlett.9b00215] |
Source(1):